Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Biogen Inc.
  6. Financials
    BIIB   US09062X1037

BIOGEN INC.

(BIIB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 60 63053 54337 67932 892--
Entreprise Value (EV)1 61 65351 73341 72335 20332 07729 677
P/E ratio 13,9x9,44x9,87x20,9x14,6x12,0x
Yield ------
Capitalization / Revenue 4,51x3,72x2,80x3,02x3,07x2,83x
EV / Revenue 4,58x3,60x3,10x3,24x3,00x2,55x
EV / EBITDA 8,76x6,41x5,56x8,12x8,16x6,65x
Price to Book 4,73x3,87x3,70x2,97x2,45x2,06x
Nbr of stocks (in thousands) 201 483180 442153 882146 893--
Reference price (USD) 301297245224224224
Announcement Date 01/29/201901/30/202002/03/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 13 45314 37813 44510 87810 70211 639
EBITDA1 7 0388 0707 5044 3363 9334 465
Operating profit (EBIT)1 6 7697 3906 8373 6663 5264 058
Operating Margin 50,3%51,4%50,9%33,7%32,9%34,9%
Pre-Tax Profit (EBT)1 5 9007 1265 0481 8882 8313 279
Net income1 4 4315 8894 0011 6042 3263 073
Net margin 32,9%41,0%29,8%14,7%21,7%26,4%
EPS2 21,631,424,810,715,318,6
Dividend per Share2 ------
Announcement Date 01/29/201901/30/202002/03/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 2 6942 7752 7792 6272 5722 624
EBITDA1 1 1851 1811 018815706820
Operating profit (EBIT)1 1 0381 108885641794821
Operating Margin 38,5%39,9%31,9%24,4%30,9%31,3%
Pre-Tax Profit (EBT)1 467582291523840816
Net income1 410449329371519540
Net margin 15,2%16,2%11,8%14,1%20,2%20,6%
EPS2 2,692,992,222,513,583,77
Dividend per Share ------
Announcement Date 04/22/202107/22/202110/20/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 1 023-4 0442 311--
Net Cash position1 -1 810--8163 215
Leverage (Debt / EBITDA) 0,15x-0,22x0,54x0,53x-0,21x-0,72x
Free Cash Flow1 5 4176 5643 8053 2783 2683 210
ROE (Net Profit / Equities) 42,0%47,7%45,2%26,3%23,5%23,6%
Shareholders' equity1 10 55812 3428 8416 0909 89513 030
ROA (Net Profit / Asset) 22,0%24,0%15,4%9,12%9,95%10,4%
Assets1 20 16124 58325 92717 57823 37229 485
Book Value Per Share2 63,676,666,275,491,5109
Cash Flow per Share2 30,238,026,225,120,723,4
Capex1 771515425298384402
Capex / Sales 5,73%3,58%3,16%2,74%3,59%3,45%
Announcement Date 01/29/201901/30/202002/03/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 32 892 216 071
Net sales (USD) 13 444 600 000
Number of employees 9 100
Sales / Employee (USD) 1 477 429
Free-Float 85,5%
Free-Float capitalization (USD) 28 108 627 305
Avg. Exchange 20 sessions (USD) 295 093 386
Average Daily Capital Traded 0,90%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA